Publicaciones en las que colabora con JUAN CARLOS NIETO GONZÁLEZ (11)

2016

  1. Multiobserver reliability of ultrasound assessment of salivary glands in patients with established primary sjögren syndrome

    Journal of Rheumatology, Vol. 43, Núm. 10, pp. 1858-1863

  2. Structural damage in rheumatoid arthritis: Comparison between tendon damage evaluated by ultrasound and radiographic damage

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1042-1046

  3. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

    Rheumatology International, Vol. 36, Núm. 3, pp. 387-396

2015

  1. Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment

    Clinical Rheumatology, Vol. 34, Núm. 5, pp. 935-942

  2. Impact of musculoskeletal ultrasound on clinical practice in paediatric rheumatology

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 583-587

  3. Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 805-811

  4. Juvenile, adult and late-onset systemic lupus erythematosus: A long-term follow-up study from a geographic and ethnically homogeneous population

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 788-794

2014

  1. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?

    Rheumatology (United Kingdom), Vol. 53, Núm. 11, pp. 2088-2094

  2. Minimum Effective Dosages of Anti-TNF in Rheumatoid Arthritis: A Cross-sectional Study

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 101-104

  3. Salivary gland ultrasound in children: A useful tool in the diagnosis of juvenile Sjögren's syndrome

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 4, pp. 578-580

2013

  1. Anti-TNF treatments in rheumatoid arthritis: Economic impact of dosage modification

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Núm. 3, pp. 407-414